Quick answers
- What is Votrient?
- Votrient is a brand name of Pazopanib, a prescription medicine. The FDA NDC Directory lists 1 Votrient product in 1 strength and form.
- Who makes Votrient?
- Novartis holds the FDA application for Votrient (NDA022465, approved October 19, 2009).
- Is there a generic or store brand of Votrient?
- Yes. The FDA NDC Directory lists 5 other products with the same active ingredients, strength and form as a Votrient product, 5 of them generic. Ask your pharmacist whether one is right for you.
- Has Votrient been recalled?
- FDA enforcement reports list 1 recall of Votrient products; the newest started November 20, 2023. A recall usually concerns specific lots, not every product.
What Votrient is
Each Votrient product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Pazopanib · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| pazopanib hydrochloride 200 mg tablet, film coated (oral) | Votrient | 5 products, 5 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Pazopanib →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022465 | Novartis | October 19, 2009 | 1 |
Companies that list Votrient
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Votrient products.
- Novartis Pharmaceuticals Corporation1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
November 20, 2023 · Class III · Completed · D-0149-2024
Failed Dissolution Specifications
Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077- — Siegfried Barbera, SL
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.